novo nordisk semaglutide shortage FDA: Nordisk's Ozempic and Wegovy, long in shortage, now available The Ozempic Shortage Is Over

Semaglutidea GLP-1 receptor agonist originally developed for type 2 diabeteshas emerged as a leading treatment for weight loss, with clinical trials showing an average 15% body weight reduction over 68 weeks

Overall tolerability of the treatment was good, with the most common side effect being nausea, particularly during treatment initiation or dose adjustments, while diarrhea was reported by 5% of patients, which was dose-dependent and easily managed

This gradual escalation helps manage the changes in body composition and energy expenditure influenced by Semaglutide

Surgeons make an incision above the pubic area, reposition the belly button if needed, and suture the muscles for a flatter contour

David Kessler, MD, explains why he believes visceral adiposity is the greatest public health failure of our lifetime

To manage this, we recommend incorporating a fiber supplement like Metamucil Gummies or an osmotic laxative like MiraLAX into your routine